x
0 Activities
0 Activities
No Saved Activities
Please wait
Home
Education
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
Search Education
Register
Contact Us
Login
Login
Remember Me
Log in
Create an account
Forgot your password?
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Credits
Specialty Area
Allergy/Clinical Immunology
Hepatology
Blood Management
Cardiology
Dermatology
Endocrinology
Epileptology
Family Medicine
Gastroenterology
Genetic Counselor
Genomic Medicine
Hematology
Hospice/Palliative Care
Hospitalist
Internal Medicine
Medical Laboratory Scientist
Neonatal/Perinatal
Neurology
Neuromuscular Specialist
Neuropsychology
Neurosurgery
Nurse
Nurse Practitioner
Nutrition
Ob/Gyn & Women's Health
Occupational Therapy
Oncology
Opthalmology
Orthopedic Surgery
Pediatrics
Pharmacist
Physical Medicine & Rehabilitation
Physician Assistant
Psychiatry/Mental Health
Pulmonary
Radiology
Rheumatology
Disease Area
Start
«
1
2
3
4
Page 4 of 4
Results 226 - 257 of 257
15
30
60
75
150
The Gut Microbiota in MS
Early MS: Induction Therapy and Escalation Strategies
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options
The Importance of Early Referral and Treatment
How to Recognize and Diagnose IPF
What Is IPF?
Download Slides: Advancing T2DM Therapy with Confidence
Getting to Goal Can Be Difficult: Louise
Getting to Goal Can Be Difficult: Brian
Considering Biosimilars in Patients Failing their Initial Biologic
When to Switch? Biologically Experienced Patients with Spondyloarthritis
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
Switching Between Biologics: Is a Biosimilar an Option?
When to Switch? Biologically Experienced Psoriasis Patients
Innovator or Biosimilar for a Patient with Psoriasis
Interchangeability and Pharmacy-Level Substitution
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
What is the Difference Between a Biosimilar and a Generic?
Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics
Are You Ready to Use Biosimilars in Your Practice?
Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?
Pharmacovigilance and Biosimilars: Any Special Considerations?
Interchangeability and Biosimilars: What will this Mean for Clinical Practice?
Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?
Biosimilars: As Safe and Effective as the Reference Product?
Drift and the Manufacturing of Biologics: What is it and Does it Matter?
Biosimilars in Clinical Practice: Interchangeability and Extrapolation
Addressing Common Barriers to Adherence
Start
«
1
2
3
4
Page 4 of 4
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept